These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4800661)

  • 1. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
    Matĕjková E; Vlastiborová A
    Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphological changes in the nucleoli of peripheral-blood lymphocytes as prognostic criteria in the chemotherapy of malignant tumors.
    Matĕjoková E; Smetana K
    Neoplasma; 1975; 22(3):303-12. PubMed ID: 1174261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of combined administration of cytembena and cyclophosphamide on the blood count and morphology of nucleoli in peripheral-blood lymphocytes in patients with malignant tumors.
    Matĕjková E
    Neoplasma; 1975; 22(1):45-54. PubMed ID: 1173938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoli of lymphocytes in the peripheral blood of patients with gastric cancer and gastric ulcer.
    Smetana K; Matĕjková E; Likovský Z; Hondlík J
    Neoplasma; 1980; 27(6):717-21. PubMed ID: 7254427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)].
    Matĕjková E; Rezábek K; Polák E
    Cesk Gastroenterol Vyz; 1974 Jul; 28(4):279-85. PubMed ID: 4603038
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nucleoli of circulating lymphocytes in adults (review and personal contribution)].
    Gentili M
    Policlinico Prat; 1970 Oct; 77(41):1307-19. PubMed ID: 4098561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some clinical data on the state of patients with inoperable cancer of the internal sex organs treated with cytembena and cyclophosphamide preparations].
    Novotna J; Jandova A; Laurova L; Skoda V
    Akush Ginekol (Mosk); 1973 Aug; 49(8):71. PubMed ID: 4800858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the nucleolar coefficient in lymphocytes in chemotherapeutically treated patients with ovarian carcinoma].
    Jandrová A; Laurová L; Skoda V; Trnka V
    Zentralbl Bakteriol Orig B; 1975; 91(9):549-51. PubMed ID: 1189808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid composition of erythrocyte membranes in patients with cancer].
    Novitskiĭ VV; Stepovaia EA; Bazhenova NG; Gol'dberg VE; Kolosova MV; Saprykina EV; Gubert EA; Sokolova IB; Koreshkova KG; Bulavina IaV
    Biull Eksp Biol Med; 1998 Aug; 126(8):204-6. PubMed ID: 9777238
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of incorporation of labelled cyclophosphamide and cytembena into human tumour.
    Jandov A ; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4725516
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of incorporation of labelled cyclophosphamide cytembena into human tumour.
    Jandová A; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4765907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of platelet aggregation in cancer patients].
    Shilova AN; Kotovshchikova EF; Lazarev AF; Barkagan ZS; Buevich EI
    Vopr Onkol; 2007; 53(6):722-3. PubMed ID: 18416146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peripheral circulating lymphocytes in patients with cancer].
    Shirakami A; Iwao N; Imagawa T; Hashizume H; Kohama T
    Saishin Igaku; 1969 Aug; 24(8):1664-71. PubMed ID: 4902061
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs.
    Kopeć J; Sitarska E; Leszko B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II clinical trial of cytembena. Clinical screening group of E.O.R.T.C.
    Biomedicine; 1977 Dec; 26(6):392-5. PubMed ID: 342004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results obtained with chemotherapy of ovarian cancer respecting its morphological structure (author's transl)].
    Skoda V; Cizková J; Hrádek D; Jandová A; Janousková M; Laurová L
    Cesk Gynekol; 1976 Dec; 41(10):716-17. PubMed ID: 1036972
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of thrombocytopoiesis in patients with cancer of the digestive tract].
    Anikin BS
    Vrach Delo; 1967 Jun; 6():18-20. PubMed ID: 5614034
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of Cytembena in man.
    Grafnetterová J; Schück O; Smahel O; König J; Růzicková S
    Neoplasma; 1971; 18(5):447-54. PubMed ID: 5119517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.